Clinical Trials Browser

Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin × 1 year × Clear all

NCT06532279 2026-02-02

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT03386500 2026-01-26

Safety Study of BMX-001 (Radio-protector) in Patients With Newly Diagnosed Anal Cancer

Phase 1/2 Active not recruiting

24 enrolled

Gastrointestinal

Anus Neoplasms

NCT02655601 2025-06-08

BMX-HGG

Phase 1/2 Completed

177 enrolled 34 charts

CNS

Astrocytoma, Glioblastoma, Glioma